Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eb61fc3ba47905ec9048959f43994b02 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-545 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55566 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0011 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-001157 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
filingDate |
2017-05-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e5b2338fc74dd0a46c5d2211ccdad3b8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d86a7269b37e2ad75a1f07b87db29c4d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_23f77904e096e4cf7710150f7b6e55e4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_066af968e9cf073cb7dcf8f34a8f7e92 |
publicationDate |
2018-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-3400959-A1 |
titleOfInvention |
Use of a vaccine targeting a cryptic tert epitope, for treating cancer in a hla-a*0201-positive patient having a non-immunogenic tumor expressing tert |
abstract |
The invention pertains to the use of a tumor vaccine composed of two peptides of nine amino acids - the WT cryptic TERT572 (RLFFYRKSV, SEQ ID No: 1) expressed by tumor cells and its optimized variant TERT572Y (YLFFYRKSV, SEQ ID No: 2) - for treating cancer in a HLA-A*0201-positive patient having a non-immunogenic tumor expressing TERT. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022180219-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-4056199-A1 |
priorityDate |
2017-05-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |